更正：卡马尔等人。使用可注射生物材料和药物涂层球囊治疗外周动脉疾病：安全性和有效性视角。2023年，，1813。 （注：原文中“2023, , 1813”表述似乎不太完整准确，但按照要求直接翻译）
Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. 2023, , 1813.
作者信息
Qamar Safi Ur Rehman, Spahić Lemana, Benolić Leo, Zivanovic Marko, Filipović Nenad
机构信息
Bioengineering Research and Development Centre (BioIRC), Prvoslava Stojanovića 6, 34000 Kragujevac, Serbia.
Faculty of Engineering, University of Kragujevac, Sestre Janjić 6, 34000 Kragujevac, Serbia.
出版信息
Pharmaceutics. 2023 Oct 30;15(11):2555. doi: 10.3390/pharmaceutics15112555.
Abstract
There was an error in the original publication [...].
摘要
原始出版物中存在一处错误[……]。
相似文献
1
Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. 2023, , 1813.
Pharmaceutics. 2023 Oct 30;15(11):2555. doi: 10.3390/pharmaceutics15112555.
2
Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective.
Pharmaceutics. 2023 Jun 25;15(7):1813. doi: 10.3390/pharmaceutics15071813.
3
Use and 1-year outcomes with conventional and drug-coated balloon angioplasty in patients with lower extremity peripheral artery disease.
Am Heart J. 2019 Nov;217:42-51. doi: 10.1016/j.ahj.2019.07.014. Epub 2019 Jul 25.
4
Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons.
Curr Cardiol Rep. 2017 Aug 24;19(10):99. doi: 10.1007/s11886-017-0913-3.
5
Dextran sulfate as a drug delivery platform for drug-coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response.
J Biomed Mater Res B Appl Biomater. 2016 Oct;104(7):1416-30. doi: 10.1002/jbm.b.33494. Epub 2015 Jul 31.
6
[Angioplasty with Sirolimus-coated Balloon: the New Standard in the Treatment of PAD?].
Zentralbl Chir. 2023 Oct;148(5):438-444. doi: 10.1055/a-2174-7770. Epub 2023 Oct 16.
7
Drug-Coated Balloons: Current Outcomes and Future Directions.
Interv Cardiol Clin. 2017 Apr;6(2):217-225. doi: 10.1016/j.iccl.2016.12.005. Epub 2017 Jan 16.
8
Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
JACC Cardiovasc Interv. 2014 Aug;7(8):827-39. doi: 10.1016/j.jcin.2014.05.008.
9
Paclitaxel-Coated Balloons and Eluting Stents: Is There a Mortality Risk in Patients With Peripheral Artery Disease?
Circulation. 2019 Oct 15;140(16):1342-1351. doi: 10.1161/CIRCULATIONAHA.119.041099. Epub 2019 Jun 10.
10
Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality.
Am Heart J. 2020 Apr;222:112-120. doi: 10.1016/j.ahj.2019.12.012. Epub 2019 Dec 28.
本文引用的文献
1
Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective.
Pharmaceutics. 2023 Jun 25;15(7):1813. doi: 10.3390/pharmaceutics15071813.
Zotero 插件